Vildagliptin, sold under the brand name Galvus among others, is an oral anti-hyperglycemic agent belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It is primarily used to manage blood sugar levels in people with type 2 diabetes by increasing the release of insulin and reducing glucose production in the liver.
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
Parent: Vildagliptin
![6,6',7,7',8,8a,8',8'a-octahydro-[3,3'-bipyrrolo[1,2-a]pyrazine]-1,1',4,4'-tetraone](https://veeprho.com/wp-content/uploads/2025/03/VE0023151-6-6-7-7-8-8a-8-8-octahydro.png "6,6',7,7',8,8a,8',8'a-octahydro-[3,3'-bipyrrolo[1,2-a]pyrazine]-1,1',4,4'-tetraone")
Parent: Vildagliptin
The production and storage of Vildagliptin may result in the formation of related compounds and impurities, which are monitored for safety and efficacy.
Advanced analytical methods like High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) are employed to detect and quantify these impurities.
Vildagliptin is used to manage type 2 diabetes by helping control blood sugar levels. It is often prescribed in combination with diet and exercise or alongside other diabetes medications.
No, Vildagliptin and Metformin are not the same. While Vildagliptin is a DPP-4 inhibitor that enhances insulin secretion, Metformin reduces glucose production in the liver. They are sometimes used together in combination therapy.
Vildapride, containing Vildagliptin, works by inhibiting the enzyme DPP-4, which increases the levels of incretin hormones. These hormones stimulate insulin secretion and decrease glucose production, helping to regulate blood sugar levels.
Yes, Vildagliptin is a DPP-4 inhibitor. It helps manage type 2 diabetes by enhancing insulin secretion and reducing glucagon release, thus improving blood sugar control.
